Healthline

Linagliptin-Metformin, Oral Tablet

Linagliptin-metformin oral tablet is available as a brand-name drug. It’s not available as a generic drug. Brand name: Jentadueto. Linagliptin-metformin comes as an immediate-release oral tablet and ...
FiercePharma

Jentadueto® (linagliptin/metformin hydrochloride) tablets receive approval for the treatment of adults with type 2 diabetes in Europe

The European Commission has approved JENTADUETO for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled on their maximally ...
FierceBiotech

Type 2 Diabetes: Investigational Empagliflozin/Linagliptin Combination Tablet Showed Reduction in Blood Glucose in Two Phase III Trials

RIDGEFIELD, Conn. and INDIANAPOLIS, June 15, 2014 -- Two phase III clinical trials found the investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels in adults ...
FierceBiotech

- Combination of linagliptin and metformin significantly reduced blood glucose levels compared with linagliptin alone

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 4, 2014 /PRNewswire/ -- The U.S. Prescribing Information for Jentadueto® (linagliptin and metformin hydrochloride) tablets now includes clinical trial data ...
FiercePharma

Video: FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes

First DPP-4 inhibitor approved at one dosage strength; no dose adjustment recommended for patients with type 2 diabetes who have kidney or liver impairment RIDGEFIELD, Conn. and INDIANAPOLIS, May 2, ...
News Medical

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens ...
Healio

FDA approves Glyxambi tablets for adults with type 2 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The U.S. Food and Drug ...
Yahoo! Sports

FDA approves Tradjenta tablets

Boehringer Ingelheim Pharmaceuticals and Eli Lilly announced the FDA has approved a supplemental new drug application for Tradjenta tablets for use as add-on therapy to insulin. Tradjenta is a ...
Nasdaq

U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes

RIDGEFIELD, Conn. and INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for the investigational fixed-dose combination ...
Healio

FDA approves first triple combination pill for type 2 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA on Monday approved the first oral therapy to ...
sciencex

New data for linagliptin to be presented at the ADA

Boehringer Ingelheim and Lilly today announced Phase III study results for linagliptin, demonstrating improved glycemic control in adults with type 2 diabetes (T2D) whose blood glucose is not ...